ANOTCH1gene copy number gain is a prognostic indicator of worse survival and a predictive biomarker to a Notch1 targeting antibody in colorectal cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ANOTCH1gene copy number gain is a prognostic indicator of worse survival and a predictive biomarker to a Notch1 targeting antibody in colorectal cancer
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 138, Issue 1, Pages 195-205
Publisher
Wiley
Online
2015-07-07
DOI
10.1002/ijc.29676
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Potent antitumor activity of cabozantinib, a c-MET and VEGFR2 inhibitor, in a colorectal cancer patient-derived tumor explant model
- (2014) Eun-Kee Song et al. INTERNATIONAL JOURNAL OF CANCER
- Antitumor Activity of the MEK Inhibitor TAK-733 against Melanoma Cell Lines and Patient-Derived Tumor Explants
- (2014) L. N. Micel et al. MOLECULAR CANCER THERAPEUTICS
- Tumours with elevated levels of the Notch and Wnt pathways exhibit efficacy to PF-03084014, a γ-secretase inhibitor, in a preclinical colorectal explant model
- (2013) J J Arcaroli et al. BRITISH JOURNAL OF CANCER
- Colon cancer progression is driven by APEX1-mediated upregulation of Jagged
- (2013) Mi-Hwa Kim et al. JOURNAL OF CLINICAL INVESTIGATION
- The Dual Pathway Inhibitor Rigosertib Is Effective in Direct Patient Tumor Xenografts of Head and Neck Squamous Cell Carcinomas
- (2013) R. T. Anderson et al. MOLECULAR CANCER THERAPEUTICS
- Notch in the Intestine: Regulation of Homeostasis and Pathogenesis
- (2012) Taeko K. Noah et al. Annual Review of Physiology
- Specific inhibition of Notch1 signaling enhances the antitumor efficacy of chemotherapy in triple negative breast cancer through reduction of cancer stem cells
- (2012) Ming Qiu et al. CANCER LETTERS
- Inhibition of MEK and PI3K/mTOR Suppresses Tumor Growth but Does Not Cause Tumor Regression in Patient-Derived Xenografts of RAS-Mutant Colorectal Carcinomas
- (2012) G. Migliardi et al. CLINICAL CANCER RESEARCH
- ALDH+ tumor-initiating cells exhibiting gain in NOTCH1 gene copy number have enhanced regrowth sensitivity to a γ-secretase inhibitor and irinotecan in colorectal cancer
- (2012) John J. Arcaroli et al. Molecular Oncology
- Suppression of Colon Cancer Metastasis by Aes through Inhibition of Notch Signaling
- (2011) Masahiro Sonoshita et al. CANCER CELL
- A Molecularly Annotated Platform of Patient-Derived Xenografts ("Xenopatients") Identifies HER2 as an Effective Therapeutic Target in Cetuximab-Resistant Colorectal Cancer
- (2011) A. Bertotti et al. Cancer Discovery
- High Level of Notch1 Protein is Associated with Poor Overall Survival in Colorectal Cancer
- (2010) Dake Chu et al. ANNALS OF SURGICAL ONCOLOGY
- Notch1 regulates the growth of human colon cancers
- (2010) Yan Zhang et al. CANCER
- NOTCH Signaling Is Required for Formation and Self-Renewal of Tumor-Initiating Cells and for Repression of Secretory Cell Differentiation in Colon Cancer
- (2010) S. S. Sikandar et al. CANCER RESEARCH
- Anti-DLL4 Inhibits Growth and Reduces Tumor-Initiating Cell Frequency in Colorectal Tumors with Oncogenic KRAS Mutations
- (2010) M. Fischer et al. CANCER RESEARCH
- Gene Array and Fluorescence In situ Hybridization Biomarkers of Activity of Saracatinib (AZD0530), a Src Inhibitor, in a Preclinical Model of Colorectal Cancer
- (2010) J. J. Arcaroli et al. CLINICAL CANCER RESEARCH
- Targeting Notch to Target Cancer Stem Cells
- (2010) A. Pannuti et al. CLINICAL CANCER RESEARCH
- DLL4 Blockade Inhibits Tumor Growth and Reduces Tumor-Initiating Cell Frequency
- (2009) Timothy Hoey et al. Cell Stem Cell
- Jagged1 is the pathological link between Wnt and Notch pathways in colorectal cancer
- (2009) V. Rodilla et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- ADAM proteases: ligand processing and modulation of the Notch pathway
- (2008) A. Zolkiewska CELLULAR AND MOLECULAR LIFE SCIENCES
- Notch1 Expression in Colorectal Carcinoma Determines Tumor Differentiation Status
- (2008) Dake Chu et al. JOURNAL OF GASTROINTESTINAL SURGERY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started